Olympus Corporation
Olympus Corporation, together with its subsidiaries, manufactures and sells medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through Endoscopic Solutions Business, Therapeutic Solutions Business, and Other segments. The company offers gastrointestinal endoscopy system products comprising video endoscopy and ultrasound systems; GI endotherapy products consisting… Read more
Olympus Corporation (OLYMY) - Net Assets
Latest net assets as of September 2025: $733.58 Billion USD
Based on the latest financial reports, Olympus Corporation (OLYMY) has net assets worth $733.58 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.38 Trillion) and total liabilities ($651.21 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $733.58 Billion |
| % of Total Assets | 52.97% |
| Annual Growth Rate | 5.67% |
| 5-Year Change | 90.08% |
| 10-Year Change | 95.62% |
| Growth Volatility | 55.44 |
Olympus Corporation - Net Assets Trend (2003–2025)
This chart illustrates how Olympus Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Olympus Corporation (2003–2025)
The table below shows the annual net assets of Olympus Corporation from 2003 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $751.73 Billion | -0.72% |
| 2024-03-31 | $757.19 Billion | +18.08% |
| 2023-03-31 | $641.23 Billion | +25.40% |
| 2022-03-31 | $511.36 Billion | +29.30% |
| 2021-03-31 | $395.48 Billion | +6.32% |
| 2020-03-31 | $371.96 Billion | -15.92% |
| 2019-03-31 | $442.39 Billion | -0.42% |
| 2018-03-31 | $444.26 Billion | +3.11% |
| 2017-03-31 | $430.88 Billion | +12.13% |
| 2016-03-31 | $384.28 Billion | +7.57% |
| 2015-03-31 | $357.25 Billion | +7.84% |
| 2014-03-31 | $331.28 Billion | +117.37% |
| 2013-03-31 | $152.41 Billion | +217.33% |
| 2012-03-31 | $48.03 Billion | -71.21% |
| 2011-03-31 | $166.84 Billion | -23.08% |
| 2010-03-31 | $216.89 Billion | +28.50% |
| 2009-03-31 | $168.78 Billion | -54.12% |
| 2008-03-31 | $367.88 Billion | +6.67% |
| 2007-03-31 | $344.87 Billion | +14.84% |
| 2006-03-31 | $300.31 Billion | +18.18% |
| 2005-03-31 | $254.12 Billion | +0.31% |
| 2004-03-31 | $253.34 Billion | +13.45% |
| 2003-03-31 | $223.31 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Olympus Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 251.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $420.97 Billion | 56.00% |
| Other Components | $330.77 Billion | 44.00% |
| Total Equity | $751.73 Billion | 100.00% |
Olympus Corporation Competitors by Market Cap
The table below lists competitors of Olympus Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Essential Utilities Inc
NYSE:WTRG
|
$11.25 Billion |
|
Chongqing Sokon Ind Grp Co
SHG:601127
|
$11.25 Billion |
|
Texas Roadhouse Inc
NASDAQ:TXRH
|
$11.25 Billion |
|
Dino Polska S.A.
PINK:DNOPF
|
$11.25 Billion |
|
Equinox Gold Corp
NYSE MKT:EQX
|
$11.23 Billion |
|
Samsung Fire & Marine Insurance
KO:000810
|
$11.23 Billion |
|
Shaanxi Coal Industry Co Ltd
SHG:601225
|
$11.23 Billion |
|
Samsara Inc
NYSE:IOT
|
$11.22 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Olympus Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 757,186,000,000 to 751,733,000,000, a change of -5,453,000,000 (-0.7%).
- Net income of 117,855,000,000 contributed positively to equity growth.
- Dividend payments of 20,981,000,000 reduced retained earnings.
- Share repurchases of 100,002,000,000 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $117.86 Billion | +15.68% |
| Dividends Paid | $20.98 Billion | -2.79% |
| Share Repurchases | $100.00 Billion | -13.3% |
| Other Changes | $-2.33 Billion | -0.31% |
| Total Change | $- | -0.72% |
Book Value vs Market Value Analysis
This analysis compares Olympus Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.02x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-03-31 | $209.84 | $12.13 | x |
| 2004-03-31 | $238.47 | $12.13 | x |
| 2005-03-31 | $228.99 | $12.13 | x |
| 2006-03-31 | $269.63 | $12.13 | x |
| 2007-03-31 | $309.03 | $12.13 | x |
| 2008-03-31 | $329.56 | $12.13 | x |
| 2009-03-31 | $150.37 | $12.13 | x |
| 2010-03-31 | $194.27 | $12.13 | x |
| 2011-03-31 | $152.36 | $12.13 | x |
| 2012-03-31 | $41.94 | $12.13 | x |
| 2013-03-31 | $134.59 | $12.13 | x |
| 2014-03-31 | $248.19 | $12.13 | x |
| 2015-03-31 | $259.85 | $12.13 | x |
| 2016-03-31 | $279.53 | $12.13 | x |
| 2017-03-31 | $313.52 | $12.13 | x |
| 2018-03-31 | $323.50 | $12.13 | x |
| 2019-03-31 | $322.91 | $12.13 | x |
| 2020-03-31 | $282.40 | $12.13 | x |
| 2021-03-31 | $306.58 | $12.13 | x |
| 2022-03-31 | $397.45 | $12.13 | x |
| 2023-03-31 | $510.62 | $12.13 | x |
| 2024-03-31 | $622.57 | $12.13 | x |
| 2025-03-31 | $655.71 | $12.13 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Olympus Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.68%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.82%
- • Asset Turnover: 0.70x
- • Equity Multiplier: 1.91x
- Recent ROE (15.68%) is above the historical average (3.17%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | 10.95% | 4.31% | 0.93x | 2.72x | $2.10 Billion |
| 2004 | 13.31% | 5.30% | 0.93x | 2.71x | $8.35 Billion |
| 2005 | -4.91% | -1.45% | 0.95x | 3.56x | $-35.91 Billion |
| 2006 | 9.83% | 2.92% | 1.00x | 3.36x | $-501.60 Million |
| 2007 | 14.30% | 4.50% | 0.97x | 3.27x | $14.38 Billion |
| 2008 | 16.27% | 5.14% | 0.83x | 3.81x | $22.33 Billion |
| 2009 | -71.15% | -11.71% | 0.89x | 6.86x | $-130.95 Billion |
| 2010 | 22.81% | 5.41% | 0.77x | 5.50x | $26.82 Billion |
| 2011 | 4.51% | 0.87% | 0.80x | 6.50x | $-8.99 Billion |
| 2012 | -109.41% | -5.77% | 0.88x | 21.59x | $-53.46 Billion |
| 2013 | 5.38% | 1.08% | 0.77x | 6.44x | $-6.89 Billion |
| 2014 | 4.13% | 1.91% | 0.69x | 3.12x | $-19.34 Billion |
| 2015 | -2.46% | -1.14% | 0.71x | 3.04x | $-44.31 Billion |
| 2016 | 16.35% | 7.78% | 0.80x | 2.61x | $24.32 Billion |
| 2017 | 18.21% | 10.45% | 0.75x | 2.31x | $35.25 Billion |
| 2018 | 12.89% | 7.26% | 0.80x | 2.21x | $12.78 Billion |
| 2019 | 1.85% | 1.03% | 0.85x | 2.11x | $-35.97 Billion |
| 2020 | 13.94% | 6.48% | 0.79x | 2.74x | $14.60 Billion |
| 2021 | 3.28% | 1.72% | 0.64x | 3.00x | $-26.51 Billion |
| 2022 | 22.73% | 13.15% | 0.65x | 2.66x | $64.95 Billion |
| 2023 | 22.41% | 16.26% | 0.58x | 2.36x | $79.42 Billion |
| 2024 | 32.04% | 26.20% | 0.60x | 2.03x | $166.85 Billion |
| 2025 | 15.68% | 11.82% | 0.70x | 1.91x | $42.68 Billion |
Industry Comparison
This section compares Olympus Corporation's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $539,803,485
- Average return on equity (ROE) among peers: -52.41%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Olympus Corporation (OLYMY) | $733.58 Billion | 10.95% | 0.89x | $11.25 Billion |
| Advanced Biomedical Technologies Inc (ABMT) | $-7.40 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $3.67 Billion | 38.07% | 1.09x | $190.05 Billion |
| Acarix AB (publ) (ACIXF) | $1.44 Million | -102.09% | 0.28x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-13.54K | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $2.76 Million | -21.69% | 0.89x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $9.28 Million | -68.70% | 0.12x | $2.76 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $1.58 Billion | 5.73% | 1.84x | $911.62 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $11.89 Million | -17.74% | 0.30x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $456.18K | -277.12% | 2.12x | $10.62 Million |